Current through Register Vol. 54, No. 50, December 14, 2024
Section 1151a.29 - Limit on medical marijuana processing(a) In the form intended to be sold to another medical marijuana organization, medical marijuana or a medical marijuana product must have a specific concentration of total THC and total CBD and must have a consistent cannabinoid profile. The concentration of the following cannabinoids shall be reported to the Department by an approved laboratory and include the following on the label (CAS numbers need not be displayed on the label): (2) THCA, if greater than 0.0%.(3) THCV, if greater than 0.0%.(5) CBDA, if greater than 0.0%.(6) CBDV, if greater than 0.0%.(7) CBN, if greater than 0.0%.(8) CBG, if greater than 0.0%.(9) CBC, if greater than 0.0%.(10) D8, if greater than 0.0%.(11) Any other cannabinoid component at 0.1%.(b) Within the first 6 months after the Department determines the grower/processor to be operational, the grower/processor shall provide the Department with a forecast of the amount of medical marijuana products it projects it will produce and in what form. The grower/ processor shall notify the Department in writing within 48 hours upon becoming aware of a potential increase or decrease in the forecasted amount occurring within any subsequent 6-month period.Adopted by Pennsylvania Bulletin, Vol 53, No. 09. March 4, 2023, effective 3/4/2023 This section cited in 28 Pa. Code § 1151a.34 (relating to packaging and labeling of medical marijuana products); and 28 Pa. Code § 1161a.28 (relating to labels and safety inserts).